Massive blood transfusion during hospitalization for delivery in new york state, 1998-2007

Jill M. Mhyre, Alexander Shilkrut, Elena V. Kuklina, William M. Callaghan, Andreea Creanga, Sari Kaminsky, Brian T. Bateman

Research output: Contribution to journalArticle

Abstract

OBJECTIVE:: To define the frequency, risk factors, and outcomes of massive transfusion in obstetrics. METHODS:: The State Inpatient Dataset for New York (1998-2007) was used to identify all delivery hospitalizations for hospitals that reported at least one delivery-related transfusion per year. Multivariable logistic regression analysis was performed to examine the relationship between maternal age, race, and relevant clinical variables and the risk of massive blood transfusion defined as 10 or more units of blood recorded. RESULTS:: Massive blood transfusion complicated 6 of every 10,000 deliveries with cases observed even in the smallest facilities. Risk factors with the strongest independent associations with massive blood transfusion included abnormal placentation (1.6/10,000 deliveries, adjusted odds ratio [OR] 18.5, 95% confidence interval [CI] 14.7-23.3), placental abruption (1.0/10,000, adjusted OR 14.6, 95% CI 11.2-19.0), severe preeclampsia (0.8/10,000, adjusted OR 10.4, 95% CI 7.7-14.2), and intrauterine fetal demise (0.7/10,000, adjusted OR 5.5, 95% CI 3.9-7.8). The most common etiologies of massive blood transfusion were abnormal placentation (26.6% of cases), uterine atony (21.2%), placental abruption (16.7%), and postpartum hemorrhage associated with coagulopathy (15.0%). A disproportionate number of women who received a massive blood transfusion experienced severe morbidity including renal failure, acute respiratory distress syndrome, sepsis, and in-hospital death. CONCLUSION:: Massive blood transfusion was infrequent, regardless of facility size. In the presence of known risk for receipt of massive blood transfusion, women should be informed of this possibility, should deliver in a well-resourced facility if possible, and should receive appropriate blood product preparation and venous access in advance of delivery.

Original languageEnglish (US)
Pages (from-to)1288-1294
Number of pages7
JournalObstetrics and Gynecology
Volume122
Issue number6
DOIs
StatePublished - Dec 2013
Externally publishedYes

Fingerprint

Blood Transfusion
Hospitalization
Odds Ratio
Confidence Intervals
Abruptio Placentae
Placentation
Uterine Inertia
Postpartum Hemorrhage
Fetal Death
Adult Respiratory Distress Syndrome
Maternal Age
Pre-Eclampsia
Obstetrics
Renal Insufficiency
Inpatients
Sepsis
Logistic Models
Regression Analysis
Morbidity

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Mhyre, J. M., Shilkrut, A., Kuklina, E. V., Callaghan, W. M., Creanga, A., Kaminsky, S., & Bateman, B. T. (2013). Massive blood transfusion during hospitalization for delivery in new york state, 1998-2007. Obstetrics and Gynecology, 122(6), 1288-1294. https://doi.org/10.1097/AOG.0000000000000021

Massive blood transfusion during hospitalization for delivery in new york state, 1998-2007. / Mhyre, Jill M.; Shilkrut, Alexander; Kuklina, Elena V.; Callaghan, William M.; Creanga, Andreea; Kaminsky, Sari; Bateman, Brian T.

In: Obstetrics and Gynecology, Vol. 122, No. 6, 12.2013, p. 1288-1294.

Research output: Contribution to journalArticle

Mhyre, JM, Shilkrut, A, Kuklina, EV, Callaghan, WM, Creanga, A, Kaminsky, S & Bateman, BT 2013, 'Massive blood transfusion during hospitalization for delivery in new york state, 1998-2007', Obstetrics and Gynecology, vol. 122, no. 6, pp. 1288-1294. https://doi.org/10.1097/AOG.0000000000000021
Mhyre, Jill M. ; Shilkrut, Alexander ; Kuklina, Elena V. ; Callaghan, William M. ; Creanga, Andreea ; Kaminsky, Sari ; Bateman, Brian T. / Massive blood transfusion during hospitalization for delivery in new york state, 1998-2007. In: Obstetrics and Gynecology. 2013 ; Vol. 122, No. 6. pp. 1288-1294.
@article{4b98620950c349f193c42957b83e0847,
title = "Massive blood transfusion during hospitalization for delivery in new york state, 1998-2007",
abstract = "OBJECTIVE:: To define the frequency, risk factors, and outcomes of massive transfusion in obstetrics. METHODS:: The State Inpatient Dataset for New York (1998-2007) was used to identify all delivery hospitalizations for hospitals that reported at least one delivery-related transfusion per year. Multivariable logistic regression analysis was performed to examine the relationship between maternal age, race, and relevant clinical variables and the risk of massive blood transfusion defined as 10 or more units of blood recorded. RESULTS:: Massive blood transfusion complicated 6 of every 10,000 deliveries with cases observed even in the smallest facilities. Risk factors with the strongest independent associations with massive blood transfusion included abnormal placentation (1.6/10,000 deliveries, adjusted odds ratio [OR] 18.5, 95{\%} confidence interval [CI] 14.7-23.3), placental abruption (1.0/10,000, adjusted OR 14.6, 95{\%} CI 11.2-19.0), severe preeclampsia (0.8/10,000, adjusted OR 10.4, 95{\%} CI 7.7-14.2), and intrauterine fetal demise (0.7/10,000, adjusted OR 5.5, 95{\%} CI 3.9-7.8). The most common etiologies of massive blood transfusion were abnormal placentation (26.6{\%} of cases), uterine atony (21.2{\%}), placental abruption (16.7{\%}), and postpartum hemorrhage associated with coagulopathy (15.0{\%}). A disproportionate number of women who received a massive blood transfusion experienced severe morbidity including renal failure, acute respiratory distress syndrome, sepsis, and in-hospital death. CONCLUSION:: Massive blood transfusion was infrequent, regardless of facility size. In the presence of known risk for receipt of massive blood transfusion, women should be informed of this possibility, should deliver in a well-resourced facility if possible, and should receive appropriate blood product preparation and venous access in advance of delivery.",
author = "Mhyre, {Jill M.} and Alexander Shilkrut and Kuklina, {Elena V.} and Callaghan, {William M.} and Andreea Creanga and Sari Kaminsky and Bateman, {Brian T.}",
year = "2013",
month = "12",
doi = "10.1097/AOG.0000000000000021",
language = "English (US)",
volume = "122",
pages = "1288--1294",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Massive blood transfusion during hospitalization for delivery in new york state, 1998-2007

AU - Mhyre, Jill M.

AU - Shilkrut, Alexander

AU - Kuklina, Elena V.

AU - Callaghan, William M.

AU - Creanga, Andreea

AU - Kaminsky, Sari

AU - Bateman, Brian T.

PY - 2013/12

Y1 - 2013/12

N2 - OBJECTIVE:: To define the frequency, risk factors, and outcomes of massive transfusion in obstetrics. METHODS:: The State Inpatient Dataset for New York (1998-2007) was used to identify all delivery hospitalizations for hospitals that reported at least one delivery-related transfusion per year. Multivariable logistic regression analysis was performed to examine the relationship between maternal age, race, and relevant clinical variables and the risk of massive blood transfusion defined as 10 or more units of blood recorded. RESULTS:: Massive blood transfusion complicated 6 of every 10,000 deliveries with cases observed even in the smallest facilities. Risk factors with the strongest independent associations with massive blood transfusion included abnormal placentation (1.6/10,000 deliveries, adjusted odds ratio [OR] 18.5, 95% confidence interval [CI] 14.7-23.3), placental abruption (1.0/10,000, adjusted OR 14.6, 95% CI 11.2-19.0), severe preeclampsia (0.8/10,000, adjusted OR 10.4, 95% CI 7.7-14.2), and intrauterine fetal demise (0.7/10,000, adjusted OR 5.5, 95% CI 3.9-7.8). The most common etiologies of massive blood transfusion were abnormal placentation (26.6% of cases), uterine atony (21.2%), placental abruption (16.7%), and postpartum hemorrhage associated with coagulopathy (15.0%). A disproportionate number of women who received a massive blood transfusion experienced severe morbidity including renal failure, acute respiratory distress syndrome, sepsis, and in-hospital death. CONCLUSION:: Massive blood transfusion was infrequent, regardless of facility size. In the presence of known risk for receipt of massive blood transfusion, women should be informed of this possibility, should deliver in a well-resourced facility if possible, and should receive appropriate blood product preparation and venous access in advance of delivery.

AB - OBJECTIVE:: To define the frequency, risk factors, and outcomes of massive transfusion in obstetrics. METHODS:: The State Inpatient Dataset for New York (1998-2007) was used to identify all delivery hospitalizations for hospitals that reported at least one delivery-related transfusion per year. Multivariable logistic regression analysis was performed to examine the relationship between maternal age, race, and relevant clinical variables and the risk of massive blood transfusion defined as 10 or more units of blood recorded. RESULTS:: Massive blood transfusion complicated 6 of every 10,000 deliveries with cases observed even in the smallest facilities. Risk factors with the strongest independent associations with massive blood transfusion included abnormal placentation (1.6/10,000 deliveries, adjusted odds ratio [OR] 18.5, 95% confidence interval [CI] 14.7-23.3), placental abruption (1.0/10,000, adjusted OR 14.6, 95% CI 11.2-19.0), severe preeclampsia (0.8/10,000, adjusted OR 10.4, 95% CI 7.7-14.2), and intrauterine fetal demise (0.7/10,000, adjusted OR 5.5, 95% CI 3.9-7.8). The most common etiologies of massive blood transfusion were abnormal placentation (26.6% of cases), uterine atony (21.2%), placental abruption (16.7%), and postpartum hemorrhage associated with coagulopathy (15.0%). A disproportionate number of women who received a massive blood transfusion experienced severe morbidity including renal failure, acute respiratory distress syndrome, sepsis, and in-hospital death. CONCLUSION:: Massive blood transfusion was infrequent, regardless of facility size. In the presence of known risk for receipt of massive blood transfusion, women should be informed of this possibility, should deliver in a well-resourced facility if possible, and should receive appropriate blood product preparation and venous access in advance of delivery.

UR - http://www.scopus.com/inward/record.url?scp=84889249190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889249190&partnerID=8YFLogxK

U2 - 10.1097/AOG.0000000000000021

DO - 10.1097/AOG.0000000000000021

M3 - Article

VL - 122

SP - 1288

EP - 1294

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 6

ER -